Atrial fibrillation and type 2 diabetes: Prevalence, etiology, pathophysiology and effect of anti-diabetic therapies

Diabetes, Obesity & Metabolism
David S H Bell, Edison Goncalves

Abstract

New-onset atrial fibrillation (NAF) is increased in the type 2 diabetic patient because of the presence of the metaboli syndrome and increased sympathetic activity. This results in inflammation, endothelial dysfunction and myocardial steatosis which, in turn, lead to atrial fibrosis and dilatation. The end result is the development of structural and electrical atrial remodeling. Drugs that lower insulin resistance, particularly pioglitazone, decrease the incidence of NAF while drugs that, through hypoglycaemia, stimulate the sympathetic nervous system, insulin and secretagogues, increase the incidence of NAF. Currently there is no evidence that GLP-1 agonists, SGLT2 inhibitors and DPP-4 inhibitors either accelerate or decelerate the development of NAF.

References

Apr 29, 1982·The New England Journal of Medicine·W B KannelP M McNamara
Aug 31, 2001·Journal of the American College of Cardiology·L PolontchoukS Dhein
Jun 12, 2002·Circulation·Marco Bettoni, Marc Zimmermann
Jun 14, 2002·Cardiovascular Research·Maurits AllessieUlrich Schotten
Nov 25, 2004·JAMA : the Journal of the American Medical Association·Thomas J WangEmelia J Benjamin
Jan 25, 2008·American Heart Journal·Nikolas WanahitaJonathan S Steinberg
Apr 21, 2010·Journal of General Internal Medicine·Sascha DublinSusan R Heckbert
May 22, 2010·Journal of the American College of Cardiology·Usha B TedrowChristine M Albert
Nov 16, 2010·Cardiovascular Research·Anne Margreet De JongIsabelle C Van Gelder
May 6, 2011·Diabetes Care·Brian M FrierSimon R Heller
May 3, 2011·The American Journal of Cardiology·Rachel R HuxleyAlvaro Alonso
May 10, 2011·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Jun GuYuanlong Wang
Jul 26, 2011·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·G VyssoulisC Stefanadis
Sep 15, 2011·Circulation Journal : Official Journal of the Japanese Circulation Society·Hiroshi WatanabeMakoto Kodama
Sep 21, 2011·International Journal of Cardiology·Tze-Fan ChaoShih-Ann Chen
Jun 12, 2012·Cell Metabolism·Ira J GoldbergP Christian Schulze
Sep 18, 2012·Journal of the American College of Cardiology·Tobias SchoenDavid Conen
Jan 4, 2013·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Deniz KarasoyJonas Bjerring Olesen
Sep 3, 2013·The New England Journal of Medicine·Benjamin M SciricaUNKNOWN SAVOR-TIMI 53 Steering Committee and Investigators
Sep 3, 2013·The New England Journal of Medicine·William B WhiteUNKNOWN EXAMINE Investigators
Jan 28, 2014·The Journal of Clinical Investigation·Aurora MerovciRalph A DeFronzo
Apr 16, 2014·The Lancet. Diabetes & Endocrinology·Markus SchlaichGavin Lambert
May 3, 2014·Journal of the American Heart Association·Roopinder K SandhuChristine M Albert
Aug 2, 2014·Cardiovascular Research·Shotaro SaitoNaohiko Takahashi
Dec 19, 2014·Circulation·Dariush MozaffarianUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee

❮ Previous
Next ❯

Citations

May 27, 2020·Journal of Diabetes Research·McKayla J NiemannLance E Davidson
Mar 12, 2019·Mini Reviews in Medicinal Chemistry·Sho-Ichi YamagishiTakanori Matsui
Sep 29, 2019·Cardiovascular Diabetology·Yi-Hsin ChanYung-Hsin Yeh
Sep 22, 2019·Medicina·Cristina-Mihaela LăcătușuBogdan-Mircea Mihai
Mar 2, 2021·Diabetes Research and Clinical Practice·Dimitrios A VrachatisGeorgios Giannopoulos
Mar 17, 2021·Cardiovascular Research·Martin AguilarSvetlana Reilly
Mar 30, 2021·Frontiers in Endocrinology·Sravya JannapureddyRavichandran Ramasamy
May 7, 2021·The International Journal of Cardiovascular Imaging·Mustafa DogdusSalih Kilic
May 18, 2021·The International Journal of Cardiovascular Imaging·Uğur Arslan
Jul 30, 2021·International Journal of Clinical Practice·Rungroj KrittayaphongUNKNOWN COOL-AF Investigators
Aug 20, 2021·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Laurent FauchierA John Camm
Jan 27, 2022·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Ven Gee LimFaizel Osman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.